Catalyst Wire Dossier Catalyst Wire Dossier

Rybelsus

semaglutide · Novo Nordisk A/S
Drug timelines are a Plus or Pro feature.

39 regulatory and trial events tracked for Rybelsus, covering 2014-04-28 to 2026-08-10. Get the full timeline:

Most recent: Clinical Trial Results: A Research Study Comparing RYBELSUS® to Other Blood Sugar Lowering Tablets in People Living in America With Type 2 Diabetes (REALYSE) [Phase 4]

See pricing